- Home
- ARQQ vs RLAY Comparison
ARQQ vs RLAY Comparison
Compare ARQQ & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQQ
- RLAY
- Stock Information
- Founded
- ARQQ 2017
- RLAY 2015
- Country
- ARQQ United Kingdom
- RLAY United States
- Employees
- ARQQ N/A
- RLAY N/A
- Industry
- ARQQ Computer Software: Prepackaged Software
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ARQQ Technology
- RLAY Health Care
- Exchange
- ARQQ Nasdaq
- RLAY Nasdaq
- Market Cap
- ARQQ 742.0M
- RLAY 803.4M
- IPO Year
- ARQQ N/A
- RLAY 2020
- Fundamental
- Price
- ARQQ $43.63
- RLAY $7.14
- Analyst Decision
- ARQQ Strong Buy
- RLAY Strong Buy
- Analyst Count
- ARQQ 1
- RLAY 8
- Target Price
- ARQQ $60.00
- RLAY $17.25
- AVG Volume (30 Days)
- ARQQ 1.0M
- RLAY 2.0M
- Earning Date
- ARQQ 12-04-2025
- RLAY 11-06-2025
- Dividend Yield
- ARQQ N/A
- RLAY N/A
- EPS Growth
- ARQQ N/A
- RLAY N/A
- EPS
- ARQQ 0.48
- RLAY N/A
- Revenue
- ARQQ $241,000.00
- RLAY $8,355,000.00
- Revenue This Year
- ARQQ $86.94
- RLAY $27.30
- Revenue Next Year
- ARQQ $1,017.32
- RLAY $7.43
- P/E Ratio
- ARQQ $102.19
- RLAY N/A
- Revenue Growth
- ARQQ N/A
- RLAY N/A
- 52 Week Low
- ARQQ $5.22
- RLAY $1.78
- 52 Week High
- ARQQ $62.00
- RLAY $7.64
- Technical
- Relative Strength Index (RSI)
- ARQQ 50.41
- RLAY 63.44
- Support Level
- ARQQ $41.50
- RLAY $6.30
- Resistance Level
- ARQQ $49.33
- RLAY $7.64
- Average True Range (ATR)
- ARQQ 5.59
- RLAY 0.44
- MACD
- ARQQ -0.60
- RLAY -0.02
- Stochastic Oscillator
- ARQQ 36.46
- RLAY 72.07
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).